Reporters : NTDTV Asia Pacific Television Huang Liangjian and Shen Weitong from Taipei
Translation, editing : Gan Yung Chyan
/ KUCINTA SETIA
Image : Video Screenshot
In order to curb the epidemic, all countries are actively seeking to develop vaccines. Taiwan’s four major players have recently reported good news, the fastest third-phase human clinical phase I trial, before the end of the year There are practitioners who can supply millions of vaccines for combat readiness.
Former Vice President Chen Jianren and Taiwanese ministers attended the biomedicine industry symposium, and the international epidemic situation was wave after wave. This year's Asian Biotechnology Conference (Biotechnology Month) will appear on July 22, and nearly 20 multinational pharmaceutical companies have signed up to participate Is to see the strength of Taiwan's biomedical industry.
Health and Welfare Minister Chen Shizhong: "I think during the epidemic, we attach great importance to these related things. After the epidemic, we should establish some structural organizations and the society should continue to pay attention. Then I believe that the future development of biotechnology industry is possible Period."
Domestic vaccine development progressed ahead, including Taiwan Guoguang Biotechnology, Lianya Biotechnology, covid vaccine developed, began to apply for phase I clinical trials in July; domestic high-end vaccine companies, in cooperation with the National Institutes of Health (NIH) Last week, I applied to the TFDA (Food and Drug Administration of the Ministry of Health, Welfare and Food) for the first clinical phase.
Chen Canjian, Vice Chairman and General Manager of High-end Vaccine Biologics, said, "I think in a very short time, whether it is a high-end vaccine or other vaccine R&D units, it should be possible to enter the first phase of clinical trials in the third quarter. In the first wave, even when we are still in the first wave, it is best to be able to vaccinate at least the first-line protection personnel in the fourth quarter of this year or at the latest in the first quarter of next year."
The Ministry of Health and Welfare recently said that in the second half of the year, in addition to purchasing vaccines abroad, it will also support domestic vaccines and provide funding for each research and development stage. Former Vice President Chen Jianren said that in the post-epidemic era, Taiwan can find many niche.
Former Vice President of the Republic of China Chen Jianren: "No matter what happens to Covid-19, Taiwan's entire plan for precise health, that is, the government is promoting, all biomedical industry plans will continue to move forward. ."
The government proposes a precise health plan in Taiwan, with the goal of taking all-age health as the vision by 2030, introducing digital technology to build a large health industry. In the post-epidemic era, the biotechnology and pharmaceutical industry has developed rapidly.
No comments:
Post a Comment